Literature DB >> 1152773

Tuberose sclerosis with malignant astrocytoma.

J M Brown.   

Abstract

A case is described of a recurrent malignant gemistocytic astrocytoma in which a diagnosis of tuberose sclerosis was made at post-mortem examination, when "rhabdomyomata" were found in the cardiac muscle and tubers in the cerebral hemispheres. Malignant degeneration of a cerebral lesion has not been described in association with tuberose sclerosis.

Entities:  

Mesh：

Year:  1975        PMID： 1152773     DOI： 10.5694/j.1326-5377.1975.tb82053.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


  7 in total

1.  Subependymal giant cell astrocytoma--a clinicopathological study of 23 cases with special emphasis on histogenesis.

Authors:  Mehar Chand Sharma; Angela Mercy Ralte; Shailesh Gaekwad; Vani Santosh; S K Shankar; Chitra Sarkar
Journal:  Pathol Oncol Res       Date:  2004-12-27       Impact factor: 3.201

Review 2.  Neurosurgical treatment of tuberous sclerosis complex lesions.

Authors:  Ignacio Pascual-Castroviejo
Journal:  Childs Nerv Syst       Date:  2011-05-24       Impact factor: 1.475

3.  Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.

Authors:  S K Kim; K C Wang; B K Cho; H W Jung; Y J Lee; Y S Chung; J Y Lee; S H Park; Y M Kim; G Choe; J G Chi
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

Review 4.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

5.  Intraventricular tumors in tuberous sclerosis.

Authors:  P Frèrebeau; J Benezech; F Segnarbieux; H Harbi; A Desy; C Marty-Double
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

6.  Tuberous sclerosis - neurosurgical indications in intraventricular tumors.

Authors:  F J Holanda; G M Holanda
Journal:  Neurosurg Rev       Date:  1980       Impact factor: 3.042

7.  Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.

Authors:  Maria Tsoli; Carol Wadham; Mark Pinese; Tim Failes; Swapna Joshi; Emily Mould; Julia X Yin; Velimir Gayevskiy; Amit Kumar; Warren Kaplan; Paul G Ekert; Federica Saletta; Laura Franshaw; Jie Liu; Andrew Gifford; Martin A Weber; Michael Rodriguez; Richard J Cohn; Greg Arndt; Vanessa Tyrrell; Michelle Haber; Toby Trahair; Glenn M Marshall; Kerrie McDonald; Mark J Cowley; David S Ziegler
Journal:  Cancer Biol Ther       Date:  2018-10-09       Impact factor: 4.742
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.